Investigational Site Number 826005

Leeds LS9 7TF

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis Relapse, Squamous Cell Lung Cancer

Studies at this site

• Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — Completed
• Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta — Stopped early